Medicines management is also important because, in common with all other treatments, medicines incur a direct financial cost to purchase and administer, and potentially wider economic costs due to adverse events or wastage.
It is important, therefore, that the potential health gains from medicines are realised and that taxpayer’s investment in medicines is spent wisely.
The focus of the strategy Remedies for Success is on the pharmaceutical needs of the individual and how these can be met over the next ten years.
The strategy aims to ensure that Wales offers an attractive and challenging environment to enable the profession to fulfil its potential and deliver high quality pharmaceutical services to the population of Wales.
A new contractual framework was introduced for community pharmacy in April 2005. Drawing on the assets of skills, expertise and experience of pharmacists and their staff and its presence in the community with a tradition of ready access to all - Community pharmacies now provide a greater range of services and are rewarded for the range and quality of those services.
The Pharmaceutical Public Health Team of Public Health Wales covers a number of key areas including Medicines Management which focuses on the clinical effectiveness, cost effectiveness and safe use of medicines.
- The Pharmaceutical Public Health Team of Public Health Wales
- Public Health Wales - Medicines management
The Chief Pharmaceutical Adviser:
- Provides independent advice on all aspects of medicines including the regulation of medicines
- Ensures that pharmaceutical services develop to meet specific healthcare needs
- Leads the modernisation of pharmaceutical services and continuing professional development of pharmacists and support staff and
- Works with other UK government departments to co-ordinate pharmaceutical advice and information.
You can find out more via the link below:
Medicines management in care homes and the prescribing of nutritional products in the Nealth Port Talbot area were highlighted as areas for potential improvement in a report to the Local Health Board.More information is available below:
The Medicines and Healthcare products Regulatory Agency (MHRA) is the government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe. The MHRA is an executive agency of the Department of Health.
The National Prescribing Centre (NPC) facilitates the promotion of high quality, cost-effective prescribing and medicines management; It provides information on medicines and their use.
The National Patient Safety Agency (NPSA) leads and contributes to improved, safe patient care by informing, supporting and influencing organisations and people working in the health sector.
The All Wales Medicines Strategy Group (AWMSG) brings together NHS clinicians, pharmacists, healthcare professionals, academics, health economists, industry representatives and patient advocates to provide advice on strategic medicines management and prescribing to the Minister for Health & Social Services.
The Welsh Medicines Resource Centre (WeMeReC) is a source of independent information on prescribing for healthcare professionals working in Wales including general practitioners, community pharmacists, medical and pharmaceutical advisers. WeMeReC promotes effective, safe, appropriate and economical prescribing of medicines. The Centre liaises with many organisations across Wales to address national and local prescribing issues and to extend the learning opportunities it offers to all relevant audiences.
The managed introduction of new medicines in Wales, of which the medicines appraisal process is a part, aims to ensure that valuable NHS resources are used responsibly to benefit patients. Medicines appraisal is the process by which the NHS decides whether the benefit to patients of a particular medicine justifies any additional cost for its purchase.
Yellow Card Centre Wales (formerly named CSM Wales) is one of five regional adverse drug reaction monitoring centres, acting on behalf of the Medicines and Healthcare products Regulatory Agency.
- Towards improving the availability of medicines for patients in Wales ('the Routledge Report')
An Implementation Group, chaired by Professor Roger Walker, Consultant in Pharmaceutical Public Health for Public Health Wales, was set up to take forward the recommendations of the expert group and published their own report in March 2010.
The Medicines Management Collaborative Programme Wales led by the National Leadership and Innovation Agency for Healthcare (NLIAH) with a goal to optimise prescribing; improve health outcomes and patients experiences when medicines are involved.
The NHS Wales Governance e-Manual is designed to assist NHS organisations in Wales develop robust governance and assurance arrangements. A lot of the information on Medicines Management has been taken from ‘The Safe and Secure Handling of Medicines a Team Approach’ (Duthie 2005) which is linked to from the page below.
The Welsh Assembly Government report Free Prescriptions Three Years On marks the third anniversary of the introduction of free prescriptions. It shows how free prescriptions are helping to improve the health of the people of Wales.
- Prescriptions dispensed in the community in Wales, 2000 to 2009 and Prescription Cost Analysis (PCA) Data
The latest National Statistics on GP prescribing produced by the Welsh Assembly Government were released on 25 August 2010 according to the arrangements approved by the UK Statistics Authority